ITC share price tumbles on new India cigarette tax — what investors watch next
1 January 2026
2 mins read

ITC share price tumbles on new India cigarette tax — what investors watch next

NEW YORK, January 1, 2026, 03:07 ET — Market closed

  • ITC shares slid about 9% in Mumbai after India notified a higher excise duty on cigarettes from Feb. 1
  • Brokerages flagged suggests higher costs and price hikes that can pressure cigarette volumes
  • Tobacco peer Godfrey Phillips India also fell sharply on the policy move

ITC Ltd (ITC.NS) fell sharply on Thursday, with the stock last down 8.9% at 367.10 rupees after India notified a higher excise duty on cigarettes. The shares traded between 402.30 and 362.70 rupees. 1

The tax shock matters because it feeds directly into retail cigarette prices, and higher prices can curb consumption. Investors also watch whether the gap between legal and illegal prices widens, lifting the illicit market and squeezing reported volumes.

India’s finance ministry late on Wednesday set an excise duty — a tax charged on specific goods — of 2,050 to 8,500 rupees per 1,000 cigarette sticks depending on length, effective Feb. 1, an order showed. The levy comes on top of an existing 40% goods-and-services tax (GST) and applies to a market of roughly 100 million smokers, Reuters reported. Jefferies said the change was negative and could hurt sales volumes, while ICICI Securities estimated it implies a 22%–28% rise in overall costs for 75–85 mm cigarettes; the brokerage said cigarettes longer than 75 mm account for about 16% of ITC’s volumes and may require price increases of 2–3 rupees per stick, with ITC leading declines on benchmark and consumer-staples gauges as peer Godfrey Phillips India fell about 14%. 2

Cigarettes above 75 mm are a smaller slice of volumes, but they tend to be higher value and are often where companies test price hikes first. That puts the market’s attention on how quickly ITC adjusts pricing ahead of the Feb. 1 start date.

India’s benchmark indexes were little changed in early trade as gains in Reliance Industries and Mahindra & Mahindra offset the drop in cigarette makers. “Benchmarks are expected to remain sideways with selective buying amid thin trading volumes due to New Year holidays across global markets,” said Siddhartha Khemka, head of research at Motilal Oswal Financial Services. 3

ITC ended 2025 at 403.00 rupees on Dec. 31 after rising 0.6% in that session, according to exchange data compiled by Yahoo Finance. 4

The selloff weighed on consumer-staples sentiment because ITC is a heavyweight in the fast-moving consumer goods (FMCG) basket. FMCG companies sell everyday items such as packaged food and soap, which tends to make policy-driven shocks show up quickly in sector moves.

The market’s near-term focus is whether ITC can pass through the higher taxes without triggering a lasting hit to volumes. Traders also watch for signs that demand shifts to untaxed cigarettes, which erodes the legal industry’s pricing power.

Before the next session, the immediate marker is whether ITC holds above 360 rupees after the drop to 362.70. A stabilisation there would suggest bargain-hunting is returning after the policy shock.

Pricing headlines will remain in the driver’s seat. With the duty scheduled to take effect on Feb. 1, investors are watching how quickly ITC and peers reset retail prices and whether they use pack changes or promotions to manage the transition.

Beyond tobacco, attention is also on the broader January earnings run-rate and the policy backdrop into India’s union budget, where traders remain alert for further changes that could hit consumption-linked sectors.

Stock Market Today

NIO stock jumps on profit alert, with Monday’s open in focus

NIO stock jumps on profit alert, with Monday’s open in focus

7 February 2026
NIO shares jumped 7.23% to $5.04 Friday after the company forecast a swing to adjusted operating profit of up to 1.2 billion yuan for the fourth quarter. Trading volume reached 90.8 million shares, far above average. Nio’s deliveries rose 72% to 124,807 vehicles in the quarter. The company said results are preliminary and unaudited, with final figures due in March.
Snap stock price bounces to $5.22 after upgrades — what traders watch next week

Snap stock price bounces to $5.22 after upgrades — what traders watch next week

7 February 2026
Snap Inc. shares closed up 2% at $5.22 Friday after a volatile week, with 94 million shares traded. The company forecast Q1 revenue below analyst expectations, despite a fourth-quarter beat and a 28% rise in active advertisers. Daily active users fell by 3 million to 474 million. Analysts remain divided, with some upgrading and others trimming price targets.
Bradesco stock drops on 2026 guidance — what BBDC4 investors watch next week

Bradesco stock drops on 2026 guidance — what BBDC4 investors watch next week

7 February 2026
Bradesco’s preferred shares fell 2.55% to 20.61 reais Friday after the bank issued 2026 guidance pointing to slower growth in some areas. Fourth-quarter recurring net income rose 20.6% to 6.5 billion reais, with 2025 ROAE at 15.2%. The Ibovespa closed up 0.45%. Bradesco ADRs ended down 0.5% at $3.98 in New York.
Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

7 February 2026
Stellantis shares plunged 23.7% to $7.28 Friday after the company disclosed about €22.2 billion in charges tied to a reset of its electric-vehicle strategy and said it will skip its 2026 dividend. The automaker flagged a preliminary net loss of €19–21 billion for the second half of 2025. Shares rose 1.6% in late after-hours trading. Investors await Feb. 26 results and a May 21 Investor Day.
Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review
Previous Story

Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review

Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT
Next Story

Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT

Go toTop